Skip to main content
Back
SGRY logo

Surgery Partners, Inc.

Data quality: 100%
SGRY
NASDAQ Healthcare Medical - Care Facilities
$11.98
▲ $0.18 (1.53%)
Mkt Cap: 1.55B
Day Range
$11.77 $12.21
52-Week Range
$11.61 $24.60
Volume
1,231,564
50D / 200D Avg
$14.62 / $18.97
Prev Close
$11.80

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -19.9 0.4
P/B 0.9 2.9
ROE % -4.5 3.7
Net Margin % -2.4 3.8
Rev Growth 5Y % 10.4 10.0
D/E 2.4 0.2

Key Takeaways

Revenue grew 10.43% annually over 5 years — strong growth
Debt/Equity of 2.35 — high leverage
Generating 195.60M in free cash flow
PEG of 0.47 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.19%
Capital efficient — spends only 2.38% of revenue on capex

Growth

Revenue Growth (5Y)
10.43%
Revenue (1Y)6.24%
Earnings (1Y)N/A
FCF Growth (3Y)-2.32%

Quality

Return on Equity
-4.45%
ROIC5.09%
Net Margin-2.35%
Op. Margin11.77%

Safety

Debt / Equity
2.35
Current Ratio1.87
Interest Coverage1.43

Valuation

P/E Ratio
-19.90
P/B Ratio0.91
EV/EBITDA13.70
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 6.24% Revenue Growth (3Y) 9.82%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 10.43% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3.31B Net Income (TTM) -77.90M
ROE -4.45% ROA -0.95%
Gross Margin 23.12% Operating Margin 11.77%
Net Margin -2.35% Free Cash Flow (TTM) 195.60M
ROIC 5.09% FCF Growth (3Y) -2.32%
Safety
Debt / Equity 2.35 Current Ratio 1.87
Interest Coverage 1.43 Dividend Yield 0.00%
Valuation
P/E Ratio -19.90 P/B Ratio 0.91
P/S Ratio 0.47 PEG Ratio 0.47
EV/EBITDA 13.70 Dividend Yield 0.00%
Market Cap 1.55B Enterprise Value 5.34B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.31B 3.11B 2.74B 2.54B 2.23B
Net Income -77.90M -168.10M -11.90M -54.60M -70.90M
EPS (Diluted) -0.61 -1.33 -0.09 -0.59 -1.12
Gross Profit 765.00M 745.60M 647.50M 574.90M 491.40M
Operating Income 389.50M 348.80M 328.00M 345.20M 302.20M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.24B 7.89B 6.88B 6.68B 6.12B
Total Liabilities 4.72B 4.25B 3.51B 3.40B 3.82B
Shareholders' Equity 1.71B 1.79B 1.99B 2.00B 1.09B
Total Debt 4.02B 3.70B 3.06B 2.93B 3.29B
Cash & Equivalents 239.90M 269.50M 195.90M 282.90M 389.90M
Current Assets 1.15B 1.12B 895.00M 921.00M 946.10M
Current Liabilities 615.50M 624.40M 523.00M 493.40M 536.80M

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#310 of 616
35

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026